Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Entrada Therapeutics (TRDA) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for Entrada Therapeutics (TRDA) over the last 2 years, with Sep 2025 value amounting to 0.14.

  • Entrada Therapeutics' Asset Utilization Ratio fell 62.30% to 0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14, marking a year-over-year decrease of 62.30%. This contributed to the annual value of 0.42 for FY2024, which is 18.37% up from last year.
  • As of Q3 2025, Entrada Therapeutics' Asset Utilization Ratio stood at 0.14, which was down 15.98% from 0.17 recorded in Q2 2025.
  • Over the past 5 years, Entrada Therapeutics' Asset Utilization Ratio peaked at 0.44 during Q2 2024, and registered a low of 0.14 during Q3 2025.
  • For the 3-year period, Entrada Therapeutics' Asset Utilization Ratio averaged around 0.31, with its median value being 0.34 (2024).
  • As far as peak fluctuations go, Entrada Therapeutics' Asset Utilization Ratio skyrocketed by 44.23% in 2024, and later crashed by 62.30% in 2025.
  • Quarterly analysis of 3 years shows Entrada Therapeutics' Asset Utilization Ratio stood at 0.27 in 2023, then surged by 44.23% to 0.39 in 2024, then tumbled by 62.30% to 0.14 in 2025.
  • Its last three reported values are 0.14 in Q3 2025, 0.17 for Q2 2025, and 0.34 during Q1 2025.